Sino Biopharma spends $951m to acquire China-based LaNova Medicines
Both AstraZeneca and MSD have secured lucrative licensing deals for two of LaNova’s oncology assets in recent years.
LEO Pharma secures rights to Boehringer’s Spevigo for $105m
Vertex and NHS England agree reimbursement for Alyftrek
WHO endorses Gilead’s Yeztugo for HIV prevention
Illimis secures funding for GAIA-based Alzheimer’s therapeutics
Scaling smart: how small pharma companies can build resilient supply chains
Analysis
View More
Themes
View MoreFive lessons from biopharma companies’ data transformation journeys
A sales rep looking up a healthcare professional's (HCP) contact details finds three records, each with conflicting information. At the same time, leadership struggles to generate accurate global reports due...
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
AI in drug discovery: from hypothetical to reality
Lisata collaborates with GATC Health on drug development
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act